ABOUT THE EXPERT

Jan A. Burger,

MD, PhD

Professor, Tenured, Department of Leukemia
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, TX

Jan A. Burger, M.D., Ph.D. is a Professor of Medicine at the MD Anderson Cancer Center in Houston, USA. Dr. Burger received his M.D./Ph.D. degree at Albert-Ludwigs-University in Freiburg, Germany, with subsequent clinical training and board certification in Internal Medicine and Hematology/Oncology at Freiburg University Hospital, before moving to MD Anderson in 2005. In 2006, Dr. Burger received the “Venia legendi” (Habilitation) for Internal Medicine at Albert-Ludwigs-University in Freiburg. Moreover, from 1996 to 1999, Dr. Burger received postdoctoral research training in Hematology and Immunology at the University of California, San Diego.

As a laboratory and clinical investigator, Dr. Burger focuses on developing new therapeutic approaches for targeting the microenvironment in CLL, other B cell malignancies, and acute leukemia. Laboratory research by Dr. Burger’s group characterized B cell chemokine receptors, such as CXCR4 and CXCR5, adhesion molecules, and B cell receptor (BCR)-associated kinases, such as SYK, BTK, and PI3 kinases as therapeutic targets. Dr. Burger serves as a principal investigator on clinical trials which explore several of these targets in CLL. For his innovative research, Dr. Burger has received several awards, among them, the Arthur Pappenheim Award by the DGHO, a Kimmel Scholar Award, ASCO Young Investigator and Career Development awards, the Leukemia and Lymphoma Society Scholar award, and the MD Anderson Faculty Scholar Award. Dr. Burger is a regular speaker at EHA and ASH, and has published in the leading Journals in his field.

CONTRIBUTING ARTICLES